Two Sigma Advisers’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-360,100
| Closed | -$1.77M | – | 2880 |
|
|
2021
Q3 | $1.77M | Sell |
360,100
-178,600
| -33% | -$877K | ﹤0.01% | 1322 |
|
|
2021
Q2 | $2.84M | Buy |
538,700
+60,600
| +13% | +$320K | 0.01% | 1132 |
|
|
2021
Q1 | $2.3M | Buy |
478,100
+310,600
| +185% | +$1.49M | 0.01% | 1202 |
|
|
2020
Q4 | $725K | Buy |
167,500
+77,200
| +85% | +$334K | ﹤0.01% | 1717 |
|
|
2020
Q3 | $372K | Buy |
90,300
+71,100
| +370% | +$293K | ﹤0.01% | 1930 |
|
|
2020
Q2 | $49K | Buy |
+19,200
| New | +$49K | ﹤0.01% | 2426 |
|
|
2018
Q2 | – | Sell |
-18,900
| Closed | -$452K | – | 2546 |
|
|
2018
Q1 | $452K | Buy |
18,900
+1,300
| +7% | +$31.1K | ﹤0.01% | 1851 |
|
|
2017
Q4 | $596K | Buy |
+17,600
| New | +$596K | ﹤0.01% | 1723 |
|
|
2016
Q1 | – | Sell |
-7,100
| Closed | -$201K | – | 2175 |
|
|
2015
Q4 | $201K | Buy |
+7,100
| New | +$201K | ﹤0.01% | 1670 |
|
|
2015
Q3 | – | Sell |
-12,900
| Closed | -$338K | – | 2051 |
|
|
2015
Q2 | $338K | Buy |
+12,900
| New | +$338K | ﹤0.01% | 1576 |
|